-
1
-
-
30144437514
-
Epidemiology of viral hepatitis and HIV co-infection
-
Alter J. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006;44(Suppl 1):56-59
-
(2006)
J Hepatol
, vol.44
, Issue.SUPPL. 1
, pp. 56-59
-
-
Alter, J.1
-
2
-
-
85062055676
-
Liver-related deaths in persons infected with the human immunodeficiency virus
-
The Data Collection on Adverse Events of Anti-HIV Study Group.
-
The Data Collection on Adverse Events of Anti-HIV Study Group. Liver-related deaths in persons infected with the human immunodeficiency virus. Arch Intern Med 2006;166:1632-1641
-
(2006)
Arch Intern Med
, vol.166
, pp. 1632-1641
-
-
-
3
-
-
0038798716
-
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients
-
DOI 10.1136/gut.52.7.1035
-
Mohsen AH, Easterbrook P, Taylor C, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003;52:1035-1040 (Pubitemid 36765298)
-
(2003)
Gut
, vol.52
, Issue.7
, pp. 1035-1040
-
-
Mohsen, A.H.1
Easterbrook, P.J.2
Taylor, C.3
Portmann, B.4
Kulasegaram, R.5
Murad, S.6
Wiselka, M.7
Norris, S.8
-
4
-
-
72549113119
-
Hepatitis C virus coinfection does not influence influence the CD4 cell recovery in HIV-1 infected patients with maximal viral suppression
-
Peters L, Morcroft A, Soriano V, et al. Hepatitis C virus coinfection does not influence influence the CD4 cell recovery in HIV-1 infected patients with maximal viral suppression. J Acquir Immune Defic Syndr 2003;33:577-584
-
(2003)
J Acquir Immune Defic Syndr
, vol.33
, pp. 577-584
-
-
Peters, L.1
Morcroft, A.2
Soriano, V.3
-
5
-
-
58149520605
-
Differences in virological response to pegylated interferon and ribavirin between hepatitis C (HCV)-monoinfected and HIV-HCV coinfected patients
-
Tural C, Galeras JA, Planas R, et al. Differences in virological response to pegylated interferon and ribavirin between hepatitis C (HCV)-monoinfected and HIV-HCV coinfected patients. Antiviral Therapy 2008;13:1047-1055
-
(2008)
Antiviral Therapy
, vol.13
, pp. 1047-1055
-
-
Tural, C.1
Galeras, J.A.2
Planas, R.3
-
6
-
-
35648952231
-
HCV-HIV coinfection: Simple messages from a complex disease
-
DOI 10.1371/journal.pmed.0040240
-
Klenerman P, Kim A. HCV-HIV coinfection: simple messages from a complex disease. PLOS Med 2007;4:e240. doi:10.1371/journal.pmed.0040240. (Pubitemid 350035450)
-
(2007)
PLoS Medicine
, vol.4
, Issue.10
, pp. 1608-1614
-
-
Klenerman, P.1
Kim, A.2
-
7
-
-
41549090888
-
HCV/HIV co-infection: Time to re-evaluate the role of HIV in the liver?
-
Blackard JT, Sherman KE. HCV/HIV co-infection: time to re-evaluate the role of HIV in the liver? J Viral Hepatitis 2008;15:323-330
-
(2008)
J Viral Hepatitis
, vol.15
, pp. 323-330
-
-
Blackard, J.T.1
Sherman, K.E.2
-
8
-
-
53549115066
-
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis
-
Thien H, Yi Q, Dore G, et al. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008;22:1979-1991
-
(2008)
AIDS
, vol.22
, pp. 1979-1991
-
-
Thien, H.1
Yi, Q.2
Dore, G.3
-
9
-
-
0036829092
-
AGA technical review on nonalcoholic fatty liver disease
-
Sanyal A. AGA technical review on non-alcoholic fatty liver disease. Gastroenterology 2002;123:1705-1725 (Pubitemid 35231670)
-
(2002)
Gastroenterology
, vol.123
, Issue.5
, pp. 1705-1725
-
-
Sanyal, A.J.1
-
10
-
-
0033038672
-
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
-
DOI 10.1016/S0016-5085(99)70506-8
-
Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology 1999;116:1413-1419 (Pubitemid 29258890)
-
(1999)
Gastroenterology
, vol.116
, Issue.6
, pp. 1413-1419
-
-
Matteoni, C.A.1
Younossi, Z.M.2
Gramlich, T.3
Boparai, N.4
Yao Chang, L.5
McCullough, A.J.6
-
11
-
-
27644478378
-
Review article: The metabolic syndrome and non-alcoholic fatty liver disease
-
Laria P, Lonardo A, Carulli L, et al. Review article: the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Phrmacol Ther 2005;22(Suppl 2):31-36 (Pubitemid 41564379)
-
(2005)
Alimentary Pharmacology and Therapeutics, Supplement
, vol.22
, Issue.2
, pp. 31-36
-
-
Loria, P.1
Lonardo, A.2
Carulli, L.3
Verrone, A.M.4
Ricchi, M.5
Lombardini, S.6
Rudilosso, A.7
Ballestri, S.8
Carulli, N.9
-
12
-
-
0035084699
-
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
-
Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatosis: associations of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192 (Pubitemid 32246672)
-
(2001)
Gastroenterology
, vol.120
, Issue.5
, pp. 1183-1192
-
-
Sanyal, A.J.1
Campbell-Sargent, C.2
Mirshahi, F.3
Rizzo, W.B.4
Contos, M.J.5
Sterling, R.K.6
Luketic, V.A.7
Shiffman, M.L.8
Clore, J.N.9
-
13
-
-
29244484291
-
Steatosis in chronic hepatitis C: Why does it really matter?
-
Asselah T, Rubia-Brandt L, Marcellin P, et al. Steatosis in chronic hepatitis C: why does it really matter? Gut 2006;55:123-130
-
(2006)
Gut
, vol.55
, pp. 123-130
-
-
Asselah, T.1
Rubia-Brandt, L.2
Marcellin, P.3
-
14
-
-
0034987263
-
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
-
DOI 10.1053/jhep.2001.24432
-
Adinolfi Le, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and co-relates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-1364 (Pubitemid 32496971)
-
(2001)
Hepatology
, vol.33
, Issue.6
, pp. 1358-1364
-
-
Adinolfi, L.E.1
Gambardella, M.2
Andreana, A.3
Tripodi, M.-F.4
Utili, R.5
Ruggiero, G.6
-
15
-
-
1542287381
-
Hepatitis C Virus Infection and Diabetes: Direct Involvement of the Virus in the Development of Insulin Resistance
-
DOI 10.1053/j.gastro.2003.11.056
-
Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004;126:840-848 (Pubitemid 38298332)
-
(2004)
Gastroenterology
, vol.126
, Issue.3
, pp. 840-848
-
-
Shintani, Y.1
Fujie, H.2
Miyoshi, H.3
Tsutsumi, T.4
Tsukamoto, K.5
Kimura, S.6
Moriya, K.7
Koike, K.8
-
16
-
-
38649120719
-
Insulin Resistance in Chronic Hepatitis C: Association with Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis
-
DOI 10.1053/j.gastro.2007.11.010, PII S0016508507020239
-
Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: association with genotypes1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008;134:416-423 (Pubitemid 351181308)
-
(2008)
Gastroenterology
, vol.134
, Issue.2
, pp. 416-423
-
-
Moucari, R.1
Asselah, T.2
Cazals-Hatem, D.3
Voitot, H.4
Boyer, N.5
Ripault, M.6
Sobesky, R.7
Martinot-Peignoux, M.8
Maylin, S.9
Nicolas-Chanoine, M.10
Paradis, V.11
Vidaud, M.12
Valla, D.13
Bedossa, P.14
Marcellin, P.15
-
17
-
-
67449151649
-
The prevalence of metabolic syndrome in Danish patients with HIV infection: The effect of antiretroviral therapy
-
Hansen BR, Petersen J, Haugaard SB, et al. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Med 2009;10:378-387
-
(2009)
HIV Med
, vol.10
, pp. 378-387
-
-
Hansen, B.R.1
Petersen, J.2
Haugaard, S.B.3
-
18
-
-
11344293751
-
Cardiovascular risk and body-fat abnormalities in HIV-infected adults
-
DOI 10.1056/NEJMra041811
-
Grinspoon S, Carr A. Cardiovascular risk and body fat abnormalities in HIV-infected adults. N Engl J Med 2005;352:48-62. (Pubitemid 40075680)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.1
, pp. 48-62
-
-
Grinspoon, S.1
Carr, A.2
-
19
-
-
0042627763
-
The effect of HAART and HCV infection on the development of hyprglycaemia among HIV-infected persons
-
Mehta SH, Moore RD, Thomas DL, et al. The effect of HAART and HCV infection on the development of hyprglycaemia among HIV-infected persons. J AcquirImmune Defic Syndr 2003;33:577-584
-
(2003)
J AcquirImmune Defic Syndr
, vol.33
, pp. 577-584
-
-
Mehta, S.H.1
Moore, R.D.2
Thomas, D.L.3
-
20
-
-
48649085310
-
Incidence and risk factors for new-onset diabetes in HIV-infected patients. the data collection on adverse events of anti-HIV drugs (D.A.D) study
-
De-Wit S, Sabin C, Weber R, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients. The data collection on adverse events of anti-HIV drugs (D.A.D) study. Diabetes Care 2008;31:1224-1229
-
(2008)
Diabetes Care
, vol.31
, pp. 1224-1229
-
-
De-Wit, S.1
Sabin, C.2
Weber, R.3
-
21
-
-
0345064200
-
Data collection on adverse events of anti-HIV drugs (DAD) study group: Combination antiretroviral therapy and the risk of myocardial infarction
-
Fris-Moller N, Sabin C, Weber R, et al. Data collection on adverse events of anti-HIV drugs (DAD) study group: combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
-
(2003)
N Engl J Med
, vol.349
, pp. 1993-2003
-
-
Fris-Moller, N.1
Sabin, C.2
Weber, R.3
-
22
-
-
41249092708
-
HIV/HCV co-infection patients: Correlates, efficacy and outcomes of anti-HCV therapy
-
Rodriguez-Torres M, Govindarajan S, Sola R, et al. HIV/HCV co-infection patients: correlates, efficacy and outcomes of anti-HCV therapy. J Hepatol 2008;48:756-764.
-
(2008)
J Hepatol
, vol.48
, pp. 756-764
-
-
Rodriguez-Torres, M.1
Govindarajan, S.2
Sola, R.3
-
23
-
-
42249105690
-
Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection
-
Sterlin RK, Contos JM, Smith PG, et al. Steatohepatitis: risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2008;47:1118-1127
-
(2008)
Hepatology
, vol.47
, pp. 1118-1127
-
-
Sterlin, R.K.1
Contos, J.M.2
Smith, P.G.3
-
24
-
-
72549110354
-
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients
-
Merchante N, Rivero A, de los Santos-Gil I, et al. Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients. Gut 2009;58:XX-XX.
-
(2009)
Gut
, vol.58
-
-
Merchante, N.1
Rivero, A.2
De Los Santos-Gil, I.3
-
25
-
-
68949205700
-
Insulin resistance is a major determinant of liver stiffness in non-diabetic patients with HCV genotype 1 chronic hepatitis
-
Petta S, Camma C, Di Marco V, et al. Insulin resistance is a major determinant of liver stiffness in non-diabetic patients with HCV genotype 1 chronic hepatitis. Aliment Pharmacol Ther 2009;30:603-613
-
(2009)
Aliment Pharmacol Ther
, vol.30
, pp. 603-613
-
-
Petta, S.1
Camma, C.2
Di Marco, V.3
|